Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Microbio CoROCO:4128 -0.97%56 EBIT per Share is NT$-1.56 as of Mar. 2026. GuruFocus rates ROCO:4128 with a GF Score™ of 56/100 and a GF Value™ of NT$44.46 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 1,585 Consumer Packaged Goods companies, Microbio Co ranks worse than 80.25% on this metric.
Microbio Co's EBIT per Share for the
three
months ended in Mar. 2026 was NT$-0.42.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NT$-1.56.
During the past 3 years, the average EBIT per Share Growth Rate was -13.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 19.70% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -8.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Microbio Co's EBIT per Share or its related term are showing as below:
ROCO:4128'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -108.2 Med: 5.9 Max: 27.6
Current: -13.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Microbio Co was 27.60% per year. The lowest was -108.20% per year. And the median was 5.90% per year.
ROCO:4128's 3-Year EBIT Growth Rate is ranked worse than 80.25% of 1585
companies
in the Consumer Packaged Goods industry
Industry Median: 7
vs ROCO:4128: -13.40
Microbio Co's EBIT for the
three
months ended in Mar. 2026 was NT$-246 Mil.
Microbio Co (ROCO:4128) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Microbio Co EBIT per Share Related Terms
Microbio Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Microbio Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-1.56
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbio Co (ROCO:4128) has a EBIT per Share of NT$-1.56 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Microbio Co and its competitors. According to the industry distribution chart, Microbio Co ranks #1272 out of 1585 companies in the Consumer Packaged Goods industry, placing it in the top 80.3%.
Is Microbio Co's EBIT per Share too high?
Microbio Co's current EBIT per Share is NT$-1.56. Based on the distribution chart, Microbio Co ranks #1272 out of 1585 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Microbio Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Microbio Co's EBIT per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Microbio Co ranks #1272 out of 1585 companies for EBIT per Share. This places Microbio Co in the lower half of its industry. The industry median EBIT per Share is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 7.00, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Microbio Co and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microbio Co's current EBIT per Share is NT$-1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbio Co stock overvalued right now?
Based on GuruFocus' analysis, Microbio Co (ROCO:4128) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$44.46, compared to a current price of NT$15.30 — trading 65.6% below its estimated fair value. The current EBIT per Share is NT$-1.56. Microbio Co's overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Microbio Co (ROCO:4128), the current EBIT per Share is NT$-1.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Microbio Co (ROCO:4128) Overvalued in 2026?
Based on GuruFocus' analysis, Microbio Co stock appears to be undervalued.
The current stock price of NT$15.30 is trading 65.6% below its estimated GF Value™ of NT$44.46.
GuruFocus considers Microbio Co to be Significantly Undervalued.
Key valuation signals for ROCO:4128:
EBIT per Share: NT$-1.56
GF Value™: NT$44.46 vs. price of NT$15.30 (65.6% below fair value)
No single metric tells the full story. See the ROCO:4128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development and the sale of dietary supplements. The majority of its revenue is generated from the sale of its dietary supplements.
56GF Score
Get the complete analysis for ROCO:4128
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4128 has been successfully added to your 
